JP2006506350A - 置換1,4−ピラジン誘導体 - Google Patents
置換1,4−ピラジン誘導体 Download PDFInfo
- Publication number
- JP2006506350A JP2006506350A JP2004536018A JP2004536018A JP2006506350A JP 2006506350 A JP2006506350 A JP 2006506350A JP 2004536018 A JP2004536018 A JP 2004536018A JP 2004536018 A JP2004536018 A JP 2004536018A JP 2006506350 A JP2006506350 A JP 2006506350A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- ring
- diethyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41026102P | 2002-09-12 | 2002-09-12 | |
| PCT/US2003/024805 WO2004024719A1 (en) | 2002-09-12 | 2003-08-27 | Substituted 1,4-pyrazine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506350A true JP2006506350A (ja) | 2006-02-23 |
| JP2006506350A5 JP2006506350A5 (cg-RX-API-DMAC10.html) | 2006-09-21 |
Family
ID=31994096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536018A Abandoned JP2006506350A (ja) | 2002-09-12 | 2003-08-27 | 置換1,4−ピラジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040116444A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1539736A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006506350A (cg-RX-API-DMAC10.html) |
| AR (1) | AR041125A1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003269949A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR0314139A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2494975A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA05002418A (cg-RX-API-DMAC10.html) |
| TW (1) | TW200503717A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004024719A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05012082A (es) * | 2003-05-09 | 2006-02-22 | Pharmacia & Upjohn Co Llc | Compuestos como antagonistas del receptor crf1. |
| US20060211710A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
| IL311645B2 (en) * | 2016-07-12 | 2025-11-01 | Revolution Medicines Inc | 2,5- disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines asallosteric shp2 inhibitors |
| CN110446709B (zh) | 2017-01-23 | 2023-09-12 | 锐新医药公司 | 作为变构shp2抑制剂的二环化合物 |
| CA3051054A1 (en) | 2017-01-23 | 2018-07-26 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
| TWI852912B (zh) | 2017-09-07 | 2024-08-21 | 美商銳新醫藥公司 | Shp2抑制劑組合物以及治療癌症的方法 |
| BR112020007058A2 (pt) | 2017-10-12 | 2020-10-06 | Revolution Medicines, Inc. | compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos |
| BR112020009757A2 (pt) | 2017-12-15 | 2020-11-03 | Revolution Medicines, Inc. | compostos policíclicos como inibidores alostéricos de shp2 |
| PL3788049T3 (pl) | 2018-05-01 | 2023-06-19 | Revolution Medicines, Inc. | Połączone z C40, C28 i C32 analogi rapamycyny jako inhibitory mTOR |
| EP3788050B1 (en) | 2018-05-01 | 2024-08-28 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| EP4531859A4 (en) | 2022-05-25 | 2026-05-27 | Revolution Medicines Inc | CANCER TREATMENT METHODS USING AN MTOR INHIBITOR |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4270297A (en) * | 1996-09-16 | 1998-04-02 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
| PA8467401A1 (es) * | 1998-02-17 | 2000-09-29 | Pfizer Prod Inc | Procedimiento para tratar la insuficiencia cardiaca |
| IL139197A0 (en) * | 1999-10-29 | 2001-11-25 | Pfizer Prod Inc | Use of corticotropin releasing factor antagonists and related compositions |
| ATE307121T1 (de) * | 2000-02-16 | 2005-11-15 | Neurogen Corp | Substituierte arylpyrazine |
-
2003
- 2003-08-27 EP EP03751841A patent/EP1539736A1/en not_active Withdrawn
- 2003-08-27 US US10/649,299 patent/US20040116444A1/en not_active Abandoned
- 2003-08-27 AU AU2003269949A patent/AU2003269949A1/en not_active Abandoned
- 2003-08-27 BR BR0314139-0A patent/BR0314139A/pt not_active IP Right Cessation
- 2003-08-27 CA CA002494975A patent/CA2494975A1/en not_active Abandoned
- 2003-08-27 MX MXPA05002418A patent/MXPA05002418A/es not_active Application Discontinuation
- 2003-08-27 JP JP2004536018A patent/JP2006506350A/ja not_active Abandoned
- 2003-08-27 WO PCT/US2003/024805 patent/WO2004024719A1/en not_active Ceased
- 2003-09-02 AR ARP030103176A patent/AR041125A1/es unknown
- 2003-09-10 TW TW092125064A patent/TW200503717A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040116444A1 (en) | 2004-06-17 |
| AR041125A1 (es) | 2005-05-04 |
| TW200503717A (en) | 2005-02-01 |
| MXPA05002418A (es) | 2005-05-27 |
| BR0314139A (pt) | 2005-07-12 |
| CA2494975A1 (en) | 2004-03-25 |
| AU2003269949A1 (en) | 2004-04-30 |
| WO2004024719A1 (en) | 2004-03-25 |
| EP1539736A1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0927171B1 (en) | Pyrazinones and triazinones and their derivatives thereof | |
| JP5560278B2 (ja) | キナーゼ阻害剤として有用なイミダゾピリダジンカルボニトリル | |
| JP2004500383A (ja) | 置換アリールピラジン | |
| SK6142000A3 (en) | HETEROARYL DIAZACYCLOALKANES AS CHOLINERGIC LIGANDS AT NICOTINICì (54) ACETYLCHOLINE RECEPTORS | |
| CN116867784A (zh) | 吡啶衍生物及其在医药上的应用 | |
| JP2004505942A (ja) | Gabaa受容体の配位子としての複素環式化合物 | |
| JP5651110B2 (ja) | 新規化合物 | |
| JPS6056982A (ja) | 3,6−ジ置換トリアゾロ〔3,4−a〕フタラジン誘導体、その製法および製薬学的組成物 | |
| JP2002510695A (ja) | 副腎皮質刺激ホルモン放出因子(CRF)拮抗剤としてのチアゾロ[4,5−d]ピリミジンおよびピリジン | |
| US20040116444A1 (en) | Substituted 1,4-pyrazine derivatives | |
| JP2006525993A (ja) | Crf1受容体拮抗剤である化合物 | |
| JP2008503444A (ja) | Crf受容体アンタゴニスト、その調製法、その医薬組成物およびその使用 | |
| CA2601600C (en) | Substituted aryl 1,4-pyrazine derivatives | |
| JP2006509729A (ja) | Crf受容体モジュレータとしての5−置換−2−アリールピラジン類 | |
| JP2006525309A (ja) | ピロロ(1,2−b)ピリダジン化合物、ならびにCRF−1受容体拮抗薬としてのその使用 | |
| WO2001068614A2 (en) | 5-substituted arylpyrimidines | |
| RU2330020C2 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ АМИНОПИРИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGIuR5 | |
| JP2005533014A (ja) | 置換ピラジン誘導体 | |
| JP2006514628A (ja) | Crf変調剤としてのピラジン化合物 | |
| JP2009501176A (ja) | グリコーゲンシンターゼキナーゼ3阻害薬としてのピリダジン化合物 | |
| JP2021512861A (ja) | 抗癌性化合物 | |
| CN120172982A (zh) | 苯并二氢呋喃类三并环化合物、其药物组合物及应用 | |
| AU2007200154B2 (en) | Compounds and methods for promoting smoking cessation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060804 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060804 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20090313 |